LEMAITRE VASCULAR INC — Director's Dealing 2022

Dec 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2022-12-11

Reporting Person: LeMaitre George W (Director, Chairman and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-11	Common Stock	M	12	—	Acquired	2491543	Direct
2022-12-11	Common Stock	F	419	$46.42	Disposed	2491124	Direct
2022-12-12	Common Stock	A	5828	—	Acquired	2496952	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-11	Dividend Equivalent Rights	$	M	12	Disposed		Common Stock (12)	Direct
2022-12-12	Stock Option (Right to Buy)	$47.19	A	30419	Acquired	2029-12-12	Common Stock (30419)	Direct

Footnotes

F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F2: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 11, 2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

F3: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.

F4: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5: The exercise price of this option to the extent it is an incentive stock option is $51.91 per share, and the exercise price of this option to the extent it is a nonqualified stock option is $47.19 per share.

F6: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.

F7: The expiration date of this option to the extent it is an incentive stock option is 12/12/2027, and the expiration date of this option to the extent it is a nonqualified stock option is 12/12/2029.